The effects of rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, on markers of endothelial cell activation, C-reactive protein, and fibrinogen levels in non-diabetic coronary artery disease patients
Year: 2003
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Institutions: St George's Hospital, St George's, University of London
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Keywords: rosiglitazone, peroxisome proliferator-activated receptor gamma agonists, coronary artery disease, non-diabetic patients, endothelial activation, C-reactive protein, fibrinogen, acute phase proteins, E-selectin, von Willebrand factor, insulin resistance, insulin sensitization, inflammation, atherosclerosis, LDL cholesterol, triglycerides
Open Access status: bronze
OpenAlex ID: W2121065969
